These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 19744601

  • 1. How to avoid nephrogenic systemic fibrosis: current guidelines in Europe and the United States.
    Thomsen HS.
    Radiol Clin North Am; 2009 Sep; 47(5):871-5, vii. PubMed ID: 19744601
    [Abstract] [Full Text] [Related]

  • 2. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 3. Nephrogenic systemic fibrosis.
    Weinreb JC, Kuo PH.
    Magn Reson Imaging Clin N Am; 2009 Feb 01; 17(1):159-67. PubMed ID: 19364606
    [Abstract] [Full Text] [Related]

  • 4. Update on nephrogenic systemic fibrosis.
    Thomsen HS, Marckmann P, Logager VB.
    Magn Reson Imaging Clin N Am; 2008 Nov 01; 16(4):551-60, vii. PubMed ID: 18926421
    [Abstract] [Full Text] [Related]

  • 5. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
    van der Molen AJ.
    J Med Imaging Radiat Oncol; 2008 Aug 01; 52(4):339-50. PubMed ID: 18811757
    [Abstract] [Full Text] [Related]

  • 6. NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe.
    Leiner T, Kucharczyk W.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1357-63. PubMed ID: 19937935
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct 01; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep 01; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 01; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 10. Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?
    Lind Ramskov K, Thomsen HS.
    Acta Radiol; 2009 Nov 01; 50(9):965-7. PubMed ID: 19863403
    [No Abstract] [Full Text] [Related]

  • 11. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul 01; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 12. Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update.
    Idée JM, Port M, Dencausse A, Lancelot E, Corot C.
    Radiol Clin North Am; 2009 Sep 01; 47(5):855-69, vii. PubMed ID: 19744600
    [Abstract] [Full Text] [Related]

  • 13. Gadolinium and nephrogenic systemic fibrosis: have we overreacted?
    Penfield JG, Reilly RF.
    Semin Dial; 2011 Sep 01; 24(5):480-6. PubMed ID: 21913988
    [Abstract] [Full Text] [Related]

  • 14. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 01; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 15. Nephrogenic systemic fibrosis.
    Bardin T, Richette P.
    Curr Opin Rheumatol; 2010 Jan 01; 22(1):54-8. PubMed ID: 19881349
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.
    Yang L, Krefting I, Gorovets A, Marzella L, Kaiser J, Boucher R, Rieves D.
    Radiology; 2012 Oct 01; 265(1):248-53. PubMed ID: 22923714
    [Abstract] [Full Text] [Related]

  • 17. Guideline to use gadolinium-based contrast agents at Kyoto University Hospital.
    Miki Y, Isoda H, Togashi K.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1364-5. PubMed ID: 19937936
    [Abstract] [Full Text] [Related]

  • 18. Nephrogenic systemic fibrosis: a review of the new conundrum.
    Goenka AH, Das CJ, Sharma R.
    Natl Med J India; 2009 Dec 01; 22(6):302-6. PubMed ID: 20384019
    [Abstract] [Full Text] [Related]

  • 19. [Guidelines for administering gadolinium-based contrast agents to patients with renal dysfunction--second edition].
    Hosoya T, Okada H, Horio M, Ohno I, Tamura S, Sugimoto H, Tsushima Y, Hayashi H, Fukuda K, Korogi Y, Yoshifumi N.
    Nihon Jinzo Gakkai Shi; 2009 Dec 01; 51(7):839-42. PubMed ID: 19928554
    [No Abstract] [Full Text] [Related]

  • 20. Current status of nephrogenic systemic fibrosis.
    Daftari Besheli L, Aran S, Shaqdan K, Kay J, Abujudeh H.
    Clin Radiol; 2014 Jul 01; 69(7):661-8. PubMed ID: 24582176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.